Menu Close

Trending

Intercept hit hard as NASH trial misses the mark
Supreme court throws Novartis a lifeline for Gilenya defense
Frontiers Health Steering Committee spotlight: Eugene Borukhovich
Babylon hires Andrew Hine to spearhead overseas expansion
Merck defends blockbuster Januvia franchise from patent challenge

Plexxikon

Oncology-Round-up-16x9-3

Oncology/ Views & Analysis/ Views and analysis

Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and more

, , , , , , , , , 0 Comment

AZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan,

X
Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and more
https://pharmaphorum.com/views-and-analysis/oncology-round-up-az-and-daiichi-score-key-trial-win-with-breast-cancer-antibody-and-more/

Login

CONTINUE TO SITE >
X
Close in 10 seconds